http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2103998-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc46d886c07fbc63138f1c300fc6ebf2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 1995-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce3891824082baafddc12f9ae738c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82df84d4ef324cc1bed7a74feb4db0fa
publicationDate 1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2103998-C1
titleOfInvention Medicinal agent for treatment of animal disease of bacterial etiology, method of treatment of gastroenteric disease of bacterial etiology in animals and method of treatment of gynecological disease of bacterial etiology in animals
abstract FIELD: veterinary science. SUBSTANCE: medicinal agent has the following components, wt.-%: rifampicin, 0.9-1.1; polymixin M sulfate, 0.9-1.1; native aubazidan, 17.5-22.5; nipagin, 0.1-0.15; citric acid, 1.0-1.2; sodium hydroxide, 0.3-0.35; and water, the balance. Optimal ratio of active components is the following, wt.-%: rifampicin, 1.0; polymixin M sulfate, 1.0. Medicinal agent can be used for treatment of gastroenteric disease in animals being preferably by oral route at dose 1 ml/kg body mass, 2 times per a day for 2-4 days. Medicinal agent can be used for treatment of gynecological disease in cows being preferably by intrauterine route at dose 200-300 ml, once per 2-3 days. EFFECT: enhanced effectiveness of agent. 5 cl, 3 tbl
priorityDate 1995-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576581

Total number of triples: 31.